ENHANCED EPIDEMIOLOGICAL SUMMARY -- PUBLIC HEALTH ONTARIO --Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to September 4, 2021
Vinay Prasad MD MPH intro'd me to this on Youtube
https://youtu.be/xzVoS-1TIWI
He suggests this link to paper
He wrote an article in June 2021 CDC's All-or-Nothing Approach to Teen COVID Vaccination Is All Wrong
Regarding the Ontario Results -- PICK ONE you like - several from Ontario Public Health
Myocarditis/pericarditis following COVID-19 mRNA vaccines remains a rare AEFI (defined by the Canadian Immunization Guide as occurring at frequency of 0.01% to less than 0.1%), even among the age groups where the highest rates of this event have been observed. 7
Results: There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose of COVID-19 mRNA vaccine and 76.8% occurred in males. The median age of individuals with a reported event was 24 years.
Myocarditis and pericarditis following COVID-19 mRNA vaccines 1 AT A GLANCE Myocarditis and Pericarditis Following COVID-19 mRNA Vaccines 2nd revision - October 1, 2021 Background In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged ...
Epidemiology of Myocarditis/Pericarditis after COVID-19 Vaccination Reporting Rate of Myocarditis/Pericarditis in the United States As of June 30, 2021, reporting rate of myocarditis overall among adults was 3.5 cases per million second doses of mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna) administered based on
Results: There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose...
In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Available information indicates that: Cases were more commonly reported after the second dose
Results There were 19,740,741 doses of mRNA vaccines administered and 297 reports of myocarditis/pericarditis meeting our inclusion criteria. Among these, 69.7% occurred following the second dose of COVID-19 mRNA vaccine and 76.8% occurred in males. The median age of individuals with a reported event was 24 years.
post-market safety surveillance on mrna covid-19 vaccines identified that when myocarditis and/or pericarditis occurs, it occurs usually within a week following vaccination, most frequently in adolescents and young adults (12 to 29 years of age), more frequently in males compared to females, and more frequently after the second dose as compared …
Study 1. "Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval" (medrxiv.org) Population: Ontario, Canada (14.7 million) who received at least one dose of COVID-19 mRNA vaccine between December 14, 2020 and September 4, 2021.
Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval
posted by Walk a Kb or Two in my cassins | 11:45 am
0 Comments:
Post a Comment
<< Home